All of our products moved to chiralix.comSince the MercachemSyncom acquisition of Chiralix (in 2018), we’ve been working hard on offering Syncom and Chiralix products from one platform/webpage. This transition has been finally achieved together with the launch of the new Symeres name. As of November 19, 2020, all products formerly available from Syncom are now available from the new Chiralix (Symeres Company) webpage (www.chiralix.com).
From hit finding to clinical proof of concept.
Syncom offers best-in-class chemistry solutions for drug discovery and early drug development. Our services span across early stage hit finding all the way to the delivery of your early clinical drug substance API (phase I/II).
Do you have a question?
Do you want to have more information about our services? Please do not hesitate to contact us.